Galapagos NV header image

Galapagos NV

GLPG

Equity

ISIN BE0003818359 / Valor 2130343

Euronext - Euronext Amsterdam (2026-11-10)
EUR 29.48-1.27%

Galapagos NV
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Galapagos NV is a Belgium-based clinical-stage biotechnology company that discovers and develops small-molecule medicines primarily for inflammatory and fibrotic diseases. Using internal discovery platforms for target identification and medicinal chemistry, the company advances candidates through preclinical and clinical development and combines an in-house pipeline with strategic partnerships to support later-stage development and commercialization; a notable collaboration with Gilead Sciences has played a central role in the development and commercial strategy for several of its assets. Galapagos is publicly listed (Euronext Brussels and Nasdaq) and focuses on disease-modifying oral therapies, maintaining research operations in Europe and the United States while managing a portfolio that has seen both clinical progress and program setbacks typical of the biotech sector.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

6.35%1Y
-12.1%3Y
-38.3%5Y

Performance

28.6%1Y
30.1%3Y
32.0%5Y

Volatility

Market cap

2163 M

Market cap (USD)

Daily traded volume (Shares)

67,213

Daily traded volume (Shares)

1 day high/low

26.36 / 25.88

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

STERIS PLC
STERIS PLC STERIS PLC Valor: 47027903
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 257.12
Basilea Pharmaceutica Ltd, Allschwil
Basilea Pharmaceutica Ltd, Allschwil Basilea Pharmaceutica Ltd, Allschwil Valor: 1143244
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.39%CHF 71.20
Molina Healthcare Inc
Molina Healthcare Inc Molina Healthcare Inc Valor: 1538184
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.48%USD 206.35
SHL Telemedicine Ltd
SHL Telemedicine Ltd SHL Telemedicine Ltd Valor: 1128957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 1.07
Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals PLC Jazz Pharmaceuticals PLC Valor: 14769757
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.77%USD 245.43
Smith & Nephew PLC
Smith & Nephew PLC Smith & Nephew PLC Valor: 1111046
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.42%USD 30.92
Addex Therapeutics Ltd
Addex Therapeutics Ltd Addex Therapeutics Ltd Valor: 2985075
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.93%CHF 0.022
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 523134
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.92%USD 22.74
Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited Valor: 12029898
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.42%INR 1,905.00
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited Valor: 11500585
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.40%INR 1,017.95